Surgical margin assessment and prognostic impact in sinonasal cancers: a systematic review and meta-analysis [0.03%]
鼻腔和鼻窦癌外科切缘评估及预后影响的系统评价和meta分析
Alberto Daniele Arosio,Elisa Coden,Alessia Lambertoni et al.
Alberto Daniele Arosio et al.
Objective: Surgery remains a cornerstone in treatment of sinonasal malignancies, but the prognostic role of margin status is controversial. This systematic review and meta-analysis evaluated the prognostic significance of...
Matching-adjusted indirect comparison of endoscopic and craniofacial resection for the treatment of sinonasal cancer invading the skull base [0.03%]
内镜与颅面切除术治疗侵犯颅底的鼻窦癌的匹配调整间接对比研究
Florian Chatelet,Sylvie Chevret,Alessandro Vinciguerra et al.
Florian Chatelet et al.
Aim: The aim of this study was to compare the efficacy and safety of endoscopic endonasal approaches (EEA) with craniofacial resection (CFR) for sinonasal cancers invading the skull base, using an unanchored matching-adjusted indirect comparison (MAIC).
Frodita Jakimovska,Igor Stojkovski,Elena Kjosevska
Frodita Jakimovska
The diagnosis and treatment of sinonasal cancers require a interdisciplinary approach and multimodality treatment.
Gender Differences in Sinonasal Cancer Incidence: Data from the Italian Registry [0.03%]
意大利肿瘤登记处的鼻窦癌发病率的性别差异
Alessandra Binazzi,Davide di Marzio,Carolina Mensi et al.
Alessandra Binazzi et al.
Background: Although rare, sinonasal cancers (SNCs) have a high occupational attributable fraction.
D Consonni,G Stoppa,A Binazzi et al.
D Consonni et al.
Background: Epithelial sinonasal cancers (SNC) are rare tumours with recognized associations with known/suspected occupational carcinogens (wood/leather dust, nickel/chromium compounds and formaldehyde).
Assessment of targeted therapy opportunities in sinonasal cancers using patient-derived functional tumor models [0.03%]
利用患者衍生的功能肿瘤模型评估鼻腔和副鼻窦癌的靶向治疗机会
Noora Lehtinen,Janne Suhonen,Kiesha Rice et al.
Noora Lehtinen et al.
Progress with next-generation molecular profiling has improved our understanding of the complexity of sinonasal cancers and resulted in the identification of an increasing number of distinct tumor entities....Despite these significant developments, the treatment of sinonasal cancers has hardly evolved since the 1980s, and an advanced sinonasal cancer presents a poor prognosis as targeted therapies are usually not available....The therapeutic vulnerabilities correlating with specific genomic background were extended and validated with in silico analyses of cancer cell lines representing different human cancers and with reported case studies of sinonasal cancers treated with targeted therapies.
Survival of Patients with Sinonasal Cancers in a Population-Based Registry, Lombardy, Italy, 2008-2023 [0.03%]
意大利伦巴第地区2008-2023年基于人群的癌症登记中鼻旁窦癌患者的生存状况
Dario Consonni,Simona Stella,Nerina Denaro et al.
Dario Consonni et al.
Sinonasal cancers (SNCs) are rare malignancies associated with occupational exposures. The aim of this study was to analyse the survival of SNC patients using data from the population-based SNC registry of the Lombardy region (10 million pe...
Assessment of social vulnerability impact in care and prognosis of sinonasal cancers in the United States [0.03%]
美国社会弱势群体在鼻窦癌症护理和预后中的影响评估
Achilles A Kanaris,David J Fei-Zhang,Lily B Fletcher et al.
Achilles A Kanaris et al.
Social determinants of health interactively influence sinonasal cancer care and prognosis. Housing-transportation and socioeconomic status showed the largest associations with disparities. The social vulnerability index can reveal the socia...
AGO2-RIP-Seq reveals miR-34/miR-449 cluster targetome in sinonasal cancers [0.03%]
AGO2-RIP-Seq揭示了鼻窦癌中miR-34/miR-449簇靶基因组
Marco Tomasetti,Federica Monaco,Corrado Rubini et al.
Marco Tomasetti et al.
Recently, using the next-generation sequencing (NGS)-based miRNome analysis the miR-34/miR-449 cluster was identified as miRNA superfamily involved in the pathogenesis of sinonasal cancers (SNCs).
Albert Y Han,Marc-Elie Nader,Keng Lam et al.
Albert Y Han et al.
Because of the comparative rarity of these cancers, sinonasal cancers are treated as a grouped diagnosis despite their clinical and biological heterogeneity.
耗时 0.09796 秒，为您在
48285708
条记录里面共找到 87 篇文章 [XML]